Axentis Pharma AG

axentispharma.com

Axentis Pharma AG is a Swiss-based pharmaceutical company focused on value-added anti-infectives in combination with novel inhalation devices. Following the entrance of a License Agreement with a Japanese partner, Axentis Pharma engaged in the development of AX-TOBRA, a liposome-based drug-device combination to combat chronic lung diseases and respiratory disorders, especially cystic fibrosis. AX-TOBRA received Orphan Designations from EU-EMA and US-FDA. To protect Axentis Pharma against loss and damage from malversations caused by its Japanese partner, Axentis Pharma initiated arbitration proceedings in Tokyo, and, ultimately, won a final and binding Arbitration Award against its former partner. The award was issued by the Japan Commercial Arbitration Association (JCAA) in Tokyo in August 2013. Currently, Axentis Pharma is seeking to enforce the Arbitration Award through judicial remedies.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

CROSSCOPE INC ALLIES WITH WALEED PHARMACY FOR PATHOLOGY SOLUTIONS IN OMAN

Crosscope Inc. | April 11, 2022

news image

Crosscope Inc. teams up with Waleed Pharmacy & Stores LLC. The latter focuses on fetching healthcare, hospital, and pharmaceutical solutions to the Sultanate of Oman, whereas Crosscope provides AI-enabled digital pathology software. Both have signed Memorandum of Understanding to facilitate a makeover in the Histopathology arena that uses Crosscope’s AI-enabled digital pathology platform. Moreover, both aim to bring pioneering technical solutions to Oman that allows comm...

Read More

PHARMA TECH

PRESCRYPTIVE HEALTH LAUNCHES COMPREHENSIVE PHARMACY MANAGEMENT PLATFORM TO EXPAND THE SCOPE OF COMMUNITY PHARMACISTS

Prescryptive Health | October 06, 2021

news image

Healthcare technology company Prescryptive Health today announced that MyRx PRO is now operational nationwide. The pharmacy management platform allows pharmacists to digitize their business with new revenue opportunities through profitable clinical services and a deeper patient engagement experience. Today we change the course of the community pharmacist, by empowering them to expand their business and meet new customers through new services, all on our secure platfo...

Read More

BUSINESS INSIGHTS

VETSOURCE UNVEILS NEW BRAND REFLECTING COMPANY'S GROWTH

Vetsource | November 17, 2022

news image

Vetsource®, a pet health company designed to provide innovative pharmacy, technology and business services to those who care for pets, launched a new brand identity to signal the official start of three brands coming together as a single, unified portfolio of solutions for the veterinary industry. Already established as a leading provider of innovative prescription management and home delivery services for veterinary practices and pet owners since 2008, Vetsource announced the...

Read More

PHARMACY MARKET

IAMA THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL DEVELOPMENT STUDIES IN DRUG-RESISTANT EPILEPSY UNDER A SERVICE AGREEMENT WITH PSYCHOGENICS

IAMA Therapeutics | July 26, 2022

news image

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service agreement to identify the efficacy of novel drug candidates in drug-resistant epilepsy. Under the...

Read More
news image

PHARMACY MARKET

CROSSCOPE INC ALLIES WITH WALEED PHARMACY FOR PATHOLOGY SOLUTIONS IN OMAN

Crosscope Inc. | April 11, 2022

Crosscope Inc. teams up with Waleed Pharmacy & Stores LLC. The latter focuses on fetching healthcare, hospital, and pharmaceutical solutions to the Sultanate of Oman, whereas Crosscope provides AI-enabled digital pathology software. Both have signed Memorandum of Understanding to facilitate a makeover in the Histopathology arena that uses Crosscope’s AI-enabled digital pathology platform. Moreover, both aim to bring pioneering technical solutions to Oman that allows comm...

Read More
news image

PHARMA TECH

PRESCRYPTIVE HEALTH LAUNCHES COMPREHENSIVE PHARMACY MANAGEMENT PLATFORM TO EXPAND THE SCOPE OF COMMUNITY PHARMACISTS

Prescryptive Health | October 06, 2021

Healthcare technology company Prescryptive Health today announced that MyRx PRO is now operational nationwide. The pharmacy management platform allows pharmacists to digitize their business with new revenue opportunities through profitable clinical services and a deeper patient engagement experience. Today we change the course of the community pharmacist, by empowering them to expand their business and meet new customers through new services, all on our secure platfo...

Read More
news image

BUSINESS INSIGHTS

VETSOURCE UNVEILS NEW BRAND REFLECTING COMPANY'S GROWTH

Vetsource | November 17, 2022

Vetsource®, a pet health company designed to provide innovative pharmacy, technology and business services to those who care for pets, launched a new brand identity to signal the official start of three brands coming together as a single, unified portfolio of solutions for the veterinary industry. Already established as a leading provider of innovative prescription management and home delivery services for veterinary practices and pet owners since 2008, Vetsource announced the...

Read More
news image

PHARMACY MARKET

IAMA THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL DEVELOPMENT STUDIES IN DRUG-RESISTANT EPILEPSY UNDER A SERVICE AGREEMENT WITH PSYCHOGENICS

IAMA Therapeutics | July 26, 2022

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service agreement to identify the efficacy of novel drug candidates in drug-resistant epilepsy. Under the...

Read More